Home › Literature › The SARS‐CoV‐2 main protease (M pro ): Structure, function, and emerging therapies for COVID‐19

Cite as: De Vuyst, Geert (3 October 2022) The SARS‐CoV‐2 main protease (M pro ): Structure, function, and emerging therapies for COVID‐19. Geert De Vuyst. https://geertdevuyst.be/en/publication/2022-hu-the-sars%e2%80%90cov%e2%80%902-main-protease-m-pro-structure-function-and-emerging-therapies-for-covid%e2%80%9019/

The SARS‐CoV‐2 main protease (M pro ): Structure, function, and emerging therapies for COVID‐19

Article English Educated

TitleThe SARS‐CoV‐2 main protease (M pro ): Structure, function, and emerging therapies for COVID‐19Author(s)Hu, Q., Xiong, Y., Zhu, G. H., Zhang, Y. N., Zhang, Y. W., Huang, P.,, & Ge, G. B.JournalMedCommVolume3Issue number3Year of publication2022DOIhttps://doi.org/10.1002/mco2. ... PublisherWileyCite asHu, Q., Xiong, Y., Zhu, G. H., Zhang, Y. N., Zhang, Y. W., Huang, P.,, & Ge, G. B. (2022). The SARS‐CoV‐2 main protease (M pro ): Structure, function, and emerging therapies for COVID‐19. MedComm, 3(3). https://doi.org/10.1002/mco2.151